Christian Nitsche
Christian Nitsche is an expert in Cardiology at Medical University of Vienna (Austria). As of October 2026, ScienceLeadR ranks Christian Nitsche in the top 1% of experts worldwide for Proteostasis Deficiencies, and in the top 1% of experts in Austria for Transthyretin Amyloid Cardiomyopathy and Transthyretin Cardiac Amyloidosis. Christian Nitsche has authored 192 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 5 of them ongoing. SLR score: 914 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Nuclear Medicine - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2018 - 2026
Number : 192
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy-Reply. PMID 42905680 — cardiovascular diseases, prealbumin, amyloid, tricuspid valve insufficiency, cardiomyopathies, transthyretin amyloid cardiomyopathy | JAMA Cardiol | 2026 | 0 |
| Definition and Prognosis of Mitral Regurgitation in Transthyretin Amyloid Cardiomyopathy: A Multicenter International Cohort Study. PMID 42866868 — heart valve diseases, mortality, cardiovascular system, cohort studies, prealbumin, amyloid, blood circulation, mitral valve insufficiency, prognosis, cardiomyopathies, transthyretin amyloid cardiomyopathy | Circulation Top journal | 2026 | 0 |
| Screening for patients at risk for cardiac amyloidosis via electronic health records: A multicenter machine learning development and validation study. PMID 42848744 — electronic health records, machine learning, amyloidosis, records, learning, radionuclide imaging | PLOS Digit Health | 2026 | 0 |
| Early and Late TAVI Outcomes in Aortic Stenosis with Transthyretin Cardiac Amyloidosis: A Systematic Review. PMID 42691439 — constriction, pathologic, mortality, aortic valve stenosis, heart failure, prealbumin, amyloidosis, transcatheter aortic valve replacement, transthyretin cardiac amyloidosis | Eur J Heart Fail | 2026 | 0 |
| Prognostic Thresholds of Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy. PMID 42671012 — mortality, laboratories, cardiovascular diseases, cohort studies, prealbumin, echocardiography, amyloid, tricuspid valve insufficiency, cardiomyopathies, transthyretin amyloid cardiomyopathy | JAMA Cardiol | 2026 | 2 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy Definition Prevalence and Prognostic Impact NCT06836011 — mitral valve, prealbumin, tricuspid valve, amyloidosis, prevalence, amyloid, tricuspid valve insufficiency, mitral valve insufficiency, prognosis, cardiomyopathies, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis | N/A | Recruiting | 2025 |
| Aortic Stenosis and Cardiac Amyloidosis NCT06129331 — constriction, pathologic, aortic valve stenosis, aortic valve, amyloidosis, therapeutics, amyloid | N/A | Recruiting | 2023 |
| Edge to edge Mitral Valve Repair in ATTR CM NCT06075823 — research design, anesthesia, safety, mitral valve, heart failure, heart, atrial fibrillation, amyloidosis, physicians, therapeutics, mitral valve insufficiency, cardiomyopathies, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis | N/A | Recruiting | 2024 |
| Post COVID 19 Outpatient Care and Biomarkers NCT05398952 — registries, laboratories, serum, fatigue syndrome, chronic, biomarkers, signs and symptoms, covid-19, myocarditis, fatigue, ambulatory care, outpatients, plasma | N/A | Recruiting | 2021 |
| Mechanisms of Excess Risk in Aortic Stenosis NCT04627987 — constriction, pathologic, aortic valve stenosis, blood, serum, fibrosis, heart failure, cicatrix, heart, arrhythmias, cardiac, troponin, biomarkers, aortic valve, death, sudden, cardiac, therapeutics, tissues, hematologic tests, walk test, blood circulation | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map